You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letters
Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants
  1. Yona Amitai1,
  2. Cathy Hammerman2
  1. 1Department of Management, Public Health and Health Administration, Bar Ilan University, Ramat Gan, Israel
  2. 2Department of Neonatology, Shaare Zedek Medical Center, Jerusalem, Israel
  1. Correspondence to Yona Amitai, Department of Management, Public Health and Health Administration, Bar Ilan University, Ramat Gan 52900, Israel yonaamitai89{at}gmail.com

https://doi.org/10.1136/fetalneonatal-2011-301204

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Barzilay et al1 stated recently that oral ibuprofen is more effective than intravenous ibuprofen for patent ductus arteriosus (PDA) closure. They attribute this superiority to pharmacokinetics; maintaining therapeutic plasma levels over a longer time extending the drug's therapeutic effect.

    In an attempt to support their conclusion, they compare ibuprofen area under the curve (AUC) 0→24 generated by their study with data …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.